Brexit: An update on preparations for MA holders

Duration: 57 minutes


Registration

If you do not wish to receive any communication from us, you may unsubscribe at any time. Click here to view our privacy policy.


Why watch

Summary

Following the outcome of the UK’s referendum on membership of the European Union, we have analyzed the most feasible Brexit scenarios and what their impacts could be for the Pharmaceutical industry.

Key Learnings

  •  How Brexit is likely to affect the obligations that come with being a MAH
  •  Why companies should be preparing systematically
  •  How a partner like PharmaLex can provide a rational and impartial perspective to achieve confidence in Brexit-readiness
speakers

A full day of inspirational speakers

Proud to bring inspirational speakers from across the globe.


 


Matthew Walker 

Director, MKW Regulatroy Solutions Ltd (until 2018: Senior Manager, Regulatory Affairs, PharmaLex)

 


 

Victor Cowper

Manager, Client Services, PharmaLex